We offer thorough memory evaluations, at no cost.

Our staff is prepared to evaluate the current status of your memory and find the right treatment option for you.

To do this, we review your medical history, perform a physical and neurological examination, and request relevant laboratory analysis to determine your overall health.

For more information, or to schedule your free evaluation, contact us.

Photo by wildpixel/iStock / Getty Images

Active Studies include

Alzheimer's Disease

Agitation

Memory Loss/Confusion

Parkinson's Disease with Depression

Major Depressive Disorder (MDD)

Bi-Polar Disease

Migraines

To qualify for these treatment trials, we encourage you to contact us by email or by calling us at (732) 244-2299. 

.

Call us for more information, or to schedule a free evaluation.

We also offer a variety of treatment options for memory loss and its related symptoms. 

Symptoms may include impairments in reasoning, judgment, language, and other cognitive abilities, as well as agitation and a lack of appetite, motivation, or sleep. 

With proper evaluation, the Memory and Aging Center can find the right treatment plan for you or your loved one.

Are your current medications not working?

We also conduct clinical research trials.

Our studies offer patients a chance to receive the most innovative medications, some of which are not yet available to the public.  These medications are administered with our patients and their caregivers in mind--we provide a compassionate environment, close physician monitoring, and a network of healthcare providers to help you along the way.

Contact us for more information. 

 

If your loved one has been diagnosed with Alzheimer’s disease and is experiencing agitation symptoms, the ADVANCE Study may be an option.

See if your loved one may qualify

The ADVANCE Study is recruiting seniors 65 to 90 years of age who have been diagnosed with Alzheimer’s disease and are experiencing agitation symptoms to take part in a clinical research study. The purpose of the study is to determine the safety and effectiveness of an investigational medication for agitation in patients with Alzheimer’s disease.

Individuals will be evaluated to determine their eligibility to participate in the study. If eligible, study participants will receive the study drug (AXS-05), an active control (bupropion), or a placebo control (inactive substance) orally as a tablet taken twice daily for five consecutive weeks. All three products look identical, but only AXS-05 contains the active drug intended to treat your loved one’s agitation. Study participants will also receive study-related medical exams and laboratory tests at no cost. Compensation for time and travel may also be available.

Here's What Our Patients Have to Say

"Everyone is so caring and they really  go out of their way to make my visits very pleasant, especially Judy - she always listens to me and never seems to be in a rush even when she has other patients waiting, she makes it seem like I am her only patient....P.S.  The office smells great and so inviting." - Terri, Toms River